Kellee Parker

Kellee Parker, DO, MCR

Languages spoken: English

Clinical Locations

Primary Children's Hospital

801-662-1000

  • Dr. Parker received her medical degree from Rocky Vista University, completed her Pediatric residency and Pediatric Hematology and Oncology Fellowship at Oregon Health & Science University. She also received additional training in clinical research through the Masters in Clinical Research program at Oregon Health & Science University.


    Dr. Parker is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology/Oncology. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children’s Hospital.


    Dr. Parker’s clinical interests include care of children with leukemia, lymphoma and various other childhood cancers. She is also interested in the long-term care of patients that have survived childhood cancer. Her research interests include improved care for childhood cancer survivors and their families and decision-making for enrollment in clinical trials within pediatric oncology.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Dr. Parker received her medical degree from Rocky Vista University, completed her Pediatric residency and Pediatric Hematology and Oncology Fellowship at Oregon Health & Science University. She also received additional training in clinical research through the Masters in Clinical Research program at Oregon Health & Science University.


    Dr. Parker is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology/Oncology. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children’s Hospital.


    Dr. Parker’s clinical interests include care of children with leukemia, lymphoma and various other childhood cancers. She is also interested in the long-term care of patients that have survived childhood cancer. Her research interests include improved care for childhood cancer survivors and their families and decision-making for enrollment in clinical trials within pediatric oncology.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Graduate Training Health Experiences Research Training - University of New Mexico Certificate
    Basic Certificate in Quality & Safety - Institute for Healthcare Improvement Certification
    Graduate Training Oregon Health & Science University M.C.R.
    Pediatric Hematology/Oncology - Oregon Health & Science University Fellow
    Residency Pediatrics - Oregon Health & Science University Resident
    Osteopathic Medicine - Rocky Vista University College of Osteopathic Medicine D.O.
    Undergraduate University of Oregon B.S.

    Selected Publications

    Journal Article

    1. Parker K, Durben N, Oleson D, Yu Y, Lim J, Recht M, Lindemulder S (2023). Hopping As an Indicator of Chemotoxicity: Gait Analysis in Patients with Leukemia and Lymphoma. Journal of Pediatric Hematology/Oncology, 45.
    2. Parker K, Christensen V, Lindemulder S, Chan L, Saxton L, Cottrell E (2023). Family Perspectives on the Transition from Active Treatment to Survivorship for Children with Cancer. Pediatr Blood Cancer.
    3. Ou JL, Bennion N, Parker KN, Fair D, Hanson HA, Kepka DL, Warner EL, Ramsay JM, Kaddas HK, Kirchhoff AC (2023). Risk factors for HPV-associated subsequent malignant neoplasms among adolescent and young adult survivors   . Cancer Epidemiol Biomarkers Prev, 32(5), 625-633.
    4. Christensen V, Parker K, Chan K, Saxton L, Cottrell E (2022). ‘Never once was I thinking the c‐word’: Parent perspectives on the facilitators and barriers to getting a childhood cancer diagnosis. J Clin Nurs.
    5. Christensen V, Parker K, Cottrell E (2021). Leveraging a qualitative data repository to integrate patient and caregiver perspectives into clinical research. J Clin Transl Sci, 5(1), e155.
    6. Parker K, Cottrell E, Stork L, Lindemulder S (2021). Parental decision making regarding consent to randomization on Children's Oncology Group AALL0932. Pediatr Blood Cancer.

    Letter

    1. Lucero OM, Parker K, Funk T, Dunlap J, Press R, Gardner RA, Chang BH (2019). Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure. [Letter to the editor]. Br J Haematol, 186(2), 333-336.